Immunohistochemistry analysis showed a significant 2-fold decrease in the expression levels of StarD13 in ovarian adenocarcinoma biopsies as compared to normal ones (Fig. 1B). This evidence concerns the gene STARD13 and ovarian adenocarcinoma.